Does SIPULEUCEL-T Cause Malignant neoplasm progression? 22 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 22 reports of Malignant neoplasm progression have been filed in association with SIPULEUCEL-T (PROVENGE). This represents 0.5% of all adverse event reports for SIPULEUCEL-T.
22
Reports of Malignant neoplasm progression with SIPULEUCEL-T
0.5%
of all SIPULEUCEL-T reports
1
Deaths
5
Hospitalizations
How Dangerous Is Malignant neoplasm progression From SIPULEUCEL-T?
Of the 22 reports, 1 (4.5%) resulted in death, 5 (22.7%) required hospitalization.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SIPULEUCEL-T. However, 22 reports have been filed with the FAERS database.
What Other Side Effects Does SIPULEUCEL-T Cause?
Chills (447)
Infusion related reaction (414)
Pyrexia (255)
Fatigue (249)
Malaise (233)
Nausea (205)
Disease progression (185)
Ill-defined disorder (185)
Culture positive (174)
Asthenia (164)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which SIPULEUCEL-T Alternatives Have Lower Malignant neoplasm progression Risk?
SIPULEUCEL-T vs SIROLIMUS
SIPULEUCEL-T vs SIRUKUMAB
SIPULEUCEL-T vs SITAGLIPTIN
SIPULEUCEL-T vs SOAP
SIPULEUCEL-T vs SODIUM